{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:52Z","timestamp":1793155732858,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,12]],"date-time":"2026-12-12T00:00:00Z","timestamp":1797033600000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["K24 AR068406"],"award-info":[{"award-number":["K24 AR068406"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01 MD015395"],"award-info":[{"award-number":["R01 MD015395"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["P30 AR072582"],"award-info":[{"award-number":["P30 AR072582"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1 TR001450"],"award-info":[{"award-number":["UL1 TR001450"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-LRP-CA"],"award-info":[{"award-number":["W81XWH-19-LRP-CA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015690","name":"South Carolina Clinical and Translational Research Institute, Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpba.2025.117302","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:31:01Z","timestamp":1764779461000},"page":"117302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lipidome changes indicate oxidative stress, inflammation, and specific loss of glycerophosphoserine inflammatory protection in patients with lupus"],"prefix":"10.1016","volume":"270","author":[{"given":"Jeremy P.","family":"Koelmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula S.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylie Anne","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7332-2228","authenticated-orcid":false,"given":"Krystal J.","family":"Godri-Pollitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-4015","authenticated-orcid":false,"given":"John A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117302_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.41128","article-title":"Improved mitochondrial metabolism and reduced inflammation following attenuation of Murine Lupus With Coenzyme Q10 analog idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.jpba.2025.117302_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40292-024-00630-8","article-title":"Effect of coenzyme Q10 supplementation on vascular endothelial function: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Daei","year":"2024","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"key":"10.1016\/j.jpba.2025.117302_bib3","doi-asserted-by":"crossref","first-page":"61118","DOI":"10.12775\/QS.2025.42.61118","article-title":"The role of coenzyme Q10 supplementation as a potential adjunct in the treatment of autoimmune diseases","volume":"42","author":"Buka\u0142a","year":"2025","journal-title":"Qual. Sport"},{"key":"10.1016\/j.jpba.2025.117302_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084576","article-title":"Coenzyme Q10 and autoimmune disorders: an overview","volume":"25","author":"Mantle","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2025.117302_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0000000000000840","article-title":"Integrating genetic and social factors to understand health disparities in lupus","volume":"33","author":"Ramos","year":"2021","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.jpba.2025.117302_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109946","article-title":"Immunometabolomics provides a new perspective for studying systemic lupus erythematosus","volume":"118","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpba.2025.117302_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpba.2019.06.005","article-title":"Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus","volume":"174","author":"Ferreira","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117302_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jpba.2025.117302_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/metabo11030142","article-title":"Lipidomics revealed aberrant metabolism of lipids including fahfas in renal tissue in the progression of Lupus Nephritis in a murine model","volume":"11","author":"Hu","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2025.117302_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep4.1825","article-title":"Lipidomics and redox lipidomics indicate early stage alcohol-induced liver damage","volume":"6","author":"Koelmel","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jpba.2025.117302_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bst0320147","article-title":"Plasmalogens: targets for oxidants and major lipophilic antioxidants","volume":"32","author":"Engelmann","year":"2004","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.jpba.2025.117302_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0961203316686707","article-title":"Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study","volume":"26","author":"Checa","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jpba.2025.117302_bib13","first-page":"857","article-title":"Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus","volume":"12","author":"Li","year":"2019","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jpba.2025.117302_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109057","article-title":"Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement","volume":"241","author":"Zhang","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.694318","article-title":"Plasma sphingolipid profile associated with subclinical atherosclerosis and clinical disease markers of systemic Lupus Erythematosus: potential predictive value","volume":"12","author":"Hammad","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.586737","article-title":"Sphingolipids and diagnosis, prognosis, and organ damage in systemic Lupus Erythematosus","volume":"11","author":"Harden","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib17","article-title":"Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biom8040105","article-title":"Shotgun lipidomics revealed altered profiles of serum lipids in systemic Lupus Erythematosus closely associated with disease activity","volume":"8","author":"Lu","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpba.2025.117302_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep4.1825","article-title":"Lipidomics and redox lipidomics indicate early stage alcohol-induced liver damage","volume":"6","author":"Koelmel","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jpba.2025.117302_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic Lupus Erythematosus in the United States: estimates from a meta-analysis of the centers for disease control and prevention National Lupus registries","volume":"73","author":"Izmirly","year":"2021","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.jpba.2025.117302_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12859-017-1744-3","article-title":"LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data","volume":"18","author":"Koelmel","year":"2017","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.jpba.2025.117302_bib22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s13361-017-1608-0","article-title":"Expanding lipidome coverage using LC-MS\/MS data-dependent acquisition with automated exclusion list generation","volume":"28","author":"Koelmel","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.117302_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/art.23416","article-title":"Autoantibody prevalence and lupus characteristics in a unique African American population","volume":"58","author":"Kamen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.117302_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ajpa.24333","article-title":"Genetic landscape of Gullah African Americans","volume":"175","author":"Zimmerman","year":"2021","journal-title":"Am. J. Phys. Anthr."},{"key":"10.1016\/j.jpba.2025.117302_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.117302_bib26","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.117302_bib27","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic Lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.117302_bib28","first-page":"630","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Comm. Progn. Stud. SLE Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.117302_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2025.117302_bib30","first-page":"513","article-title":"Lipidomics and redox lipidomics indicate early stage alcohol-induced liver damage","volume":"6","author":"Koelmel","year":"2022","journal-title":"HepatolCommun"},{"key":"10.1016\/j.jpba.2025.117302_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-017-1280-1","article-title":"Improved experimental data processing for UHPLC\u2013HRMS\/MS lipidomics applied to nonalcoholic fatty liver disease","volume":"13","author":"Patterson","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2025.117302_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.chroma.2016.04.082","article-title":"Retention behavior of lipids in reversed-phase ultrahigh-performance liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"1450","author":"Ov\u010da\u010d\u00edkov\u00e1","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.117302_bib33","doi-asserted-by":"crossref","first-page":"13523","DOI":"10.1021\/acs.analchem.8b03436","article-title":"Optimization of electrospray ionization source parameters for lipidomics to reduce misannotation of in-source fragments as precursor ions","volume":"90","author":"Gathungu","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117302_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12859-019-2803-8","article-title":"Software tool for internal standard based normalization of lipids, and effect of data-processing strategies on resulting values","volume":"20","author":"Koelmel","year":"2019","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.jpba.2025.117302_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"10.1016\/j.jpba.2025.117302_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2017.02.016","article-title":"Common cases of improper lipid annotation using high-resolution tandem mass spectrometry data and corresponding limitations in biological interpretation","volume":"1862","author":"Koelmel","year":"2017","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.jpba.2025.117302_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2019.05.004","article-title":"Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE","volume":"205","author":"Ye","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/antiox12081627","article-title":"Biomarkers of oxidative stress in systemic Lupus Erythematosus patients with active nephritis","volume":"12","author":"Liu","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.jpba.2025.117302_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep43936","article-title":"Plasmalogen biosynthesis is spatiotemporally regulated by sensing plasmalogens in the inner leaflet of plasma membranes","volume":"7","author":"Honsho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2025.117302_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.975176","article-title":"Phosphatidylserine, inflammation, and central nervous system diseases","volume":"14","author":"Ma","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpba.2025.117302_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jpba.2025.117302_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/ar1191","article-title":"Phosphatidylserine receptor and apoptosis: consequences of a non-ingested meal","volume":"6","author":"Botto","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jpba.2025.117302_bib43","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1111\/1756-185X.13689","article-title":"Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity","volume":"22","author":"Sawada","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jpba.2025.117302_bib44","first-page":"1","article-title":"B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation","author":"Ma","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jpba.2025.117302_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/antiox10020261","article-title":"Nutraceuticals against oxidative stress in autoimmune disorders","volume":"10","author":"Mannucci","year":"2021","journal-title":"Antioxidants"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:42:24Z","timestamp":1773898944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525006430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S0731708525006430"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117302","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidome changes indicate oxidative stress, inflammation, and specific loss of glycerophosphoserine inflammatory protection in patients with lupus","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117302"}}